In MRL/lpr mice that exhibit systemic autoimmune disease similar to human SLE, treatment with a BTK inhibitor ameliorated cognitive function and reduced accumulation of T cells, B cells and macrophages in the CNS (Chalmers et al. 2018). This evidence concerns the gene BTK and systemic lupus erythematosus.